Expression of MHC class II, interleukin 2 receptor and CD45 antigens on tumour-associated T lymphocytes in colonic carcinoma.
Norazmi
M N
MN
Department of Clinical Immunology, Flinders Medical Centre, Bedford Park, South Australia.
Hohmann
A W
AW
Skinner
J M
JM
Bradley
J
J
D000943:Antigens, Differentiation; D003110:Colonic Neoplasms / Q000276:immunology* / Q000473:pathology; D006681:HLA-D Antigens / Q000032:analysis*; D006649:Histocompatibility Antigens; D006801:Humans; D017493:Leukocyte Common Antigens; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000032:analysis; D015375:Receptors, Interleukin-2 / Q000032:analysis*; D013601:T-Lymphocytes / Q000032:analysis* / Q000276:immunology
D000943:Antigens, Differentiation; D006681:HLA-D Antigens; D006649:Histocompatibility Antigens; D008562:Membrane Glycoproteins; D015375:Receptors, Interleukin-2; D017493:Leukocyte Common Antigens